News
NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a discovery and clinical-stage cancer biotechnology company, today announced the dosing of the first patient in a Phase I/II clinical trial evaluating ...
NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback